Bare lymphocyte syndrome. Consequences of absent class II major histocompatibility antigen expression for B lymphocyte differentiation and function.
AUTOR(ES)
Clement, L T
RESUMO
The bare lymphocyte syndrome is a rare combined immunodeficiency disorder associated with the absence of class I and/or class II major histocompatibility (MHC) antigens. Although it has been inferred that the immune deficiency is a consequence of disordered MHC-restricted interactions among otherwise normal cells, the biological capabilities and differentiation of B lymphocytes deficient in class II MHC antigens have not been rigorously analyzed. We have examined the phenotypic and functional attributes of B cells with absent class II MHC antigens. Our data demonstrate that these B cells are intrinsically defective in their responses to membrane-mediated activation stimuli. In addition, virtually all the B cells had phenotypic evidence of arrested differentiation at an immature stage. Finally, these B cells also failed to express the C3d-EBV receptor normally present on all B lymphocytes. These data indicate that class II MHC molecules are vital participants in early events of the B cell activation cascade, and that other non-MHC membrane molecules may also be absent as a consequence of either arrested differentiation or as a result of the basic defect affecting the expression of MHC membrane antigens.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=442513Documentos Relacionados
- Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.
- Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function.
- Molecular analysis of the bare lymphocyte syndrome.
- Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
- Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.